Genezen

Hear from our Chairman & CEO, Steve Favaloro, on what drives us at Genezen: “As I look to the future, I’m incredibly bullish on cell and gene therapy—and on delivery vehicles like AAV, LVV, and RVV—to help transform great science into repeatable, manufacturable medicines that reach patients.” This spotlight comes as we mark the one-year anniversary of the transformative acquisition of our Lexington, MA site and celebrate key milestones, including: ⬆️ Welcoming 100+ new employees across the organization, strengthening our deep technical expertise ✅ Successful regulatory inspections, reinforcing our commitment to quality, compliance, and commercial readiness 🧪 Continued progress toward our vision of being a best-in-class viral vector CDMO We’re proud to partner with innovators at every stage—from early discovery through commercialization—to help bring these critical therapies to life. Thank you to BiotechTV for this great spotlight on our year of growth. #biotech #CDMO #viralvectors #genetherapy #celltherapy #manufacturing #AAV #LVV #RVV #partnership #innovation #precisionmedicine #qualityandcompliance

Encouraging long-term data continues to emerge for gene therapy in hemophilia B. New five-year Phase 3 results for CSL’s HEMGENIX® show durable Factor IX expression, sustained bleed reduction, and freedom from routine prophylaxis following a single infusion — reinforcing the therapy’s lasting clinical benefit. Congratulations to our partners at CSL on this important milestone. We are proud to support advancements that are shaping the future of gene therapy for the hemophilia community. 🙌 Read the full article from Cell & Gene here: https://lnkd.in/eWqY66PK

ONE WEEK UNTIL JPM 2026 Don’t miss your chance to see us during the 44th Annual J.P. Morgan Healthcare Conference, January 12–15!  Steve Favaloro, Susan D'Costa, Megan Hardy, and Shelly West, MBA will be there and would love to discuss your viral vector program.  Drop your info at this link to schedule time to meet with us in San Francisco: https://lnkd.in/ej5uSuAD  Let’s bring therapies to life, together.   #CDMO #viralvectors #biotech #precisionmedicine #genetherapy #JPM #JPMHealthcare2026 

We are incredibly grateful for the partnerships gained and strengthened this year. May 2026 see continued focus and success as we work together to serve patients by bringing therapies to life. Happy New Year from all of us at Genezen. #CDMO #viralvectors #precisionmedicine #biotech #NewYear #2026 #genetherapy

🎉 One year. Big momentum. Even bigger plans ahead. 🚀 One year after acquiring our Lexington, MA commercial viral vector manufacturing facility, Team Genezen has accomplished so much: scaling GMP capabilities, supporting critical programs, and growing together along the way. This milestone year reflects what's possible when experience, purpose, and execution come together. Huge thanks to the people behind the progress, and the partners who rely on us to bring their therapies to life. 👉 Read more about the journey and what's next: https://lnkd.in/etPUz_ia #TeamGenezen #CDMO #GeneTherapy #CellTherapy #Biotech #Biomanufacturing BiotechTV

Wishing you and yours a safe and happy holiday season. From all of us at Genezen ❄️

Doing CMC right is what we do best. Hear from our CEO & Chairman Steve Favaloro, who is passionate about serving our clients - and patients - with our best-in-class manufacturing and quality controls. At Genezen, we are bringing therapies to life - together.

🎁 GENEZEN CARES: HOLIDAY EDITION 🎁 Genezen teammates gathered for end-of-year celebrations packed with great food, gratitude, and a giving spirit.    Our Lexington site participated in The Salvation Army Giving Tree program, pairing our team with a local family in need. We were honored to sponsor a family of six children (ages 2-13) recently placed in foster care. Thanks to the incredible generosity of our employees—and leadership from Supply Chain Director Kaitlin Bonk—we fulfilled every wish, from cozy winter gear to art and science kits and toys for each child.     Our 3rd annual Marine Toys for Tots Foundation drive at our Indianapolis site has been a huge success as well, with the donation box overflowing with new, unwrapped toys. Through the gift of a new toy, this program helps bring the joy of Christmas and send a message of hope to America’s economically disadvantaged children. We are proud of our team’s generosity and commitment to serving our communities this holiday season. #GenezenCares #CDMO #viralvectors #biotech #genetherapy #precisionmedicine #giving #holidays #tistheseason

Indiana University invited local biotech companies to speak to their students. We were honored to participate in their Biotechnology Seminar with Dave Wilhite representing Genezen. He covered what we do as a viral vector CDMO and also discussed career paths for students with a biology degree. A chemist who started his career working in a lab, Dave has had a variety of roles since then and opened the students' eyes to the possibilities that await them. The future is bright as we work to bring therapies to life! #CDMO #viralvectors #genetherapy #biotech #precisionmedicine #IndianaUniversity #careers

We're headed to San Francisco for the 44th Annual J.P. Morgan Healthcare Conference, January 12–15! Steve Favaloro, Susan D'Costa, Megan Hardy, and Shelly West, MBA will be there and would love to connect to discuss your program. Schedule time to meet with us while we’re in San Francisco—link below. A healthier tomorrow starts today. Let’s bring therapies to life, together.